Pancreatic Cancer Research

ResearcherRadboud University Medical CenterActive in the last 2 years

Erwin J. M. van Geenen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3518-7744; OpenAlex author ID A5110789634, A5110926561. Sources: ClinicalTrials.gov.

Their work

Papers
6 (first author 1, last author 0)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 1 trial · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 6

  1. Quantitative CT Perfusion as a prognostic biomarker for chemotherapy response in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00261-026-05420-5↗
  2. Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical Trial. Co-author DOI 10.1001/jamasurg.2023.7872↗
  3. Qualitative flow metabolic phenotype of pancreatic cancer. A new prognostic biomarker? Co-author DOI 10.1016/j.hpb.2023.11.010↗
  4. Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: towards adequate staging and follow-up of pancreatic… Co-author DOI 10.1186/s12885-020-07226-0↗
  5. Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): a multicenter stepped-wedge cluster randomized controlled t… Co-author DOI 10.1186/s13063-020-4180-z↗
  6. Improving preoperative detection of synchronous liver metastases in pancreatic cancer with combined contrast-enhanced and diffusion-weighted MRI. First author DOI 10.1007/s00261-018-1867-7↗

Trials 1

  1. Micro-Tech FNB Needle to Obtain Tissue Specimens of Pancreas Malignancy for Personalized Based Chemotherapy Principal investigator NCT05249075↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John J. Hermans · 4 shared papers, 2019–2026 · strength 0.76
  2. Cees J. H. M. van Laarhoven · 3 shared papers, 2019–2024 · strength 0.44
  3. Deniece Rivière · 3 shared papers, 2019–2024 · strength 0.44
  4. Geke Litjens · 2 shared papers, 2020–2026 · strength 0.43
  5. Lodewijk A.A. Brosens · 2 shared papers, 2020–2024 · strength 0.34
  6. T. H. Perik · 1 shared paper, 2026 · strength 0.32
  7. Natália Alves · 1 shared paper, 2026 · strength 0.32
  8. Martijn W.J. Stommel · 1 shared paper, 2026 · strength 0.32
  9. HenkJan J. Huisman · 1 shared paper, 2026 · strength 0.32
  10. Erik H.J.G. Aarntzen · 1 shared paper, 2024 · strength 0.22
  11. David Kuang-Fu Chang · 1 shared paper, 2024 · strength 0.22
  12. Martin Gotthardt · 1 shared paper, 2024 · strength 0.22
  13. Irıs D. Nagtegaal · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.